Association between continuous positive airway pressure and circulating omentin levels in patients with obstructive sleep apnoea

Sleep and Breathing

Volumn 20, Issue 3, 2016, Pages 939-945

  Uygur, Firat ^a   Tanrıverdi, Hakan ^a   Can, Murat ^a   Erboy, Fatma ^a   Altınsoy, Bulent ^a   Atalay, Figen ^a   Ornek, Tacettin ^a   Damar, Murat ^a   Kokturk, Furuzan ^a   Tor, Meltem ^a  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

Author keywords

Cardiovascular diseases; Continuous positive airway pressure; Inflammation; Obstructive sleep apnoea syndrome; Omentin

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; OMENTIN; UNCLASSIFIED DRUG; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; ITLN1 PROTEIN, HUMAN; LECTIN; OXYGEN;

ADULT; APNEA HYPOPNEA INDEX; ARTERIAL OXYGEN SATURATION; ARTICLE; BIOCHEMICAL ANALYSIS; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DIABETES MELLITUS; EPWORTH SLEEPINESS SCALE; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OXYGEN DESATURATION; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; POSITIVE END EXPIRATORY PRESSURE VENTILATOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SLEEP DISORDERED BREATHING; SMOKING; AGED; BLOOD; FOLLOW UP; METABOLISM; NEWBORN; PROCEDURES; SLEEP APNEA, OBSTRUCTIVE;

ADULT; AGED; C-REACTIVE PROTEIN; CONTINUOUS POSITIVE AIRWAY PRESSURE; CYTOKINES; FEMALE; FOLLOW-UP STUDIES; GPI-LINKED PROTEINS; HUMANS; INFANT, NEWBORN; LECTINS; MALE; MIDDLE AGED; OXYGEN; POLYSOMNOGRAPHY; PROSPECTIVE STUDIES; SLEEP APNEA, OBSTRUCTIVE;

EID: 84955248284     PISSN: 15209512     EISSN: 15221709     Source Type: Journal    
DOI: 10.1007/s11325-016-1315-2     Document Type: Article

References (24)

1. Committee A-DCS (1997) The international classification of sleep disorders. Diagnostic and Coding Manual, Ed 2
2. Peker Y, Hedner J, Norum J, Kraiczi H, Carlson J (2002) Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 166(2):159–165. doi:10.1164/rccm.2105124
3. Heitmann J, Ehlenz K, Penzel T, Becker HF, Grote L, Voigt KH, Peter JH, Vogelmeier C (2004) Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients. Eur Respir J 23(2):255–262
4. Yin J, Hou P, Wu Z, Nie Y (2015) Decreased levels of serum omentin-1 in patients with inflammatory bowel disease. Med Sci Monit 21:118–122. doi:10.12659/MSM.892081
5. Yamawaki H, Tsubaki N, Mukohda M, Okada M, Hara Y (2010) Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels. Biochem Biophys Res Commun 393(4):668–672. doi:10.1016/j.bbrc.2010.02.053
6. El-Mesallamy HO, El-Derany MO, Hamdy NM (2011) Serum omentin-1 and chemerin levels are interrelated in patients with type 2 diabetes mellitus with or without ischaemic heart disease. Diabet Med 28(10):1194–1200. doi:10.1111/j.1464-5491.2011.03353.x
7. Zhong X, Zhang H-y, Tan H, Zhou Y, Liu F-l, Chen F-q, Shang D-y (2011) Association of serum omentin-1 levels with coronary artery disease. Acta Pharmacol Sin 32(7):873–878. doi:10.1038/aps.2011.26
8. Jaikanth C, Gurumurthy P, Cherian KM, Indhumathi T (2013) Emergence of omentin as a pleiotropic adipocytokine. Exp Clin Endocrinol Diabetes 121(7):377–383. doi:10.1055/s-0033-1345123
9. Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14(6):540–545
10. Berry RB BR, Gamaldo CE, Harding SM, Marcus CL, Vaughn BV (2012) for the American Academy of Sleep Medicine. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, Version 2.0. www.aasmnet.org. Accessed 13 March 2014
11. Kokturk O, Ciftci TU, Mollarecep E, Ciftci B (2005) Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome. Int Heart J 46(5):801–809
12. Ryan S, Taylor CT, McNicholas WT (2009) Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Thorax 64(7):631–636. doi:10.1136/thx.2008.105577
13. Schäffler A, Neumeier M, Herfarth H, Fürst A, Schölmerich J, Büchler C (2005) Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta 1732(1–3):96–102. doi:10.1016/j.bbaexp.2005.11.005
14. Yamawaki H, Kuramoto J, Kameshima S, Usui T, Okada M, Hara Y (2011) Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. Biochem Biophys Res Commun 408(2):339–343. doi:10.1016/j.bbrc.2011.04.039
15. Moreno-Navarrete JM, Catalán V, Ortega F, Gómez-Ambrosi J, Ricart W, Frühbeck G, Fernández-Real JM (2010) Circulating omentin concentration increases after weight loss. Nutr Metab (Lond) 7:27. doi:10.1186/1743-7075-7-27
16. Kurt OK, Tosun M, Alcelik A, Yilmaz B, Talay F (2014) Serum omentin levels in patients with obstructive sleep apnea. Sleep Breath 18(2):391–395. doi:10.1007/s11325-013-0898-0
17. Zirlik S, Hildner KM, Targosz A, Neurath MF, Fuchs FS, Brzozowski T, Konturek PC (2013) Melatonin and omentin: influence factors in the obstructive sleep apnoea syndrome? J Physiol Pharmacol 64(3):353–360
18. Wang Q, Feng X, Zhou C, Li P, Kang J (2013) Decreased levels of serum omentin-1 in patients with obstructive sleep apnoea syndrome. Ann Clin Biochem 50(Pt 3):230–235. doi:10.1177/0004563212473275
19. Guo Y, Pan L, Ren D, Xie X (2013) Impact of continuous positive airway pressure on C-reactive protein in patients with obstructive sleep apnea: a meta-analysis. Sleep Breath 17(2):495–503. doi:10.1007/s11325-012-0722-2
20. Marin JM, Carrizo SJ, Vicente E, Agusti AGN (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365(9464):1046–1053. doi:10.1016/s0140-6736(05)71141-7
21. Xie X, Pan L, Ren D, Du C, Guo Y (2013) Effects of continuous positive airway pressure therapy on systemic inflammation in obstructive sleep apnea: a meta-analysis. Sleep Med 14(11):1139–1150. doi:10.1016/j.sleep.2013.07.006
22. Garcia JM, Sharafkhaneh H, Hirshkowitz M, Elkhatib R, Sharafkhaneh A (2011) Weight and metabolic effects of CPAP in obstructive sleep apnea patients with obesity. Respir Res 12(1):80. doi:10.1186/1465-9921-12-80
23. Ishida K, Kato M, Kato Y, Yanagihara K, Kinugasa Y, Kotani K, Igawa O, Hisatome I, Shigemasa C, Somers VK (2009) Appropriate use of nasal continuous positive airway pressure decreases elevated C-reactive protein in patients with obstructive sleep apnea. Chest 136(1):125–129. doi:10.1378/chest.08-1431
24. Colish J, Walker JR, Elmayergi N, Almutairi S, Alharbi F, Lytwyn M, Francis A, Bohonis S, Zeglinski M, Kirkpatrick IDC, Sharma S, Jassal DS (2012) Obstructive sleep apnea: effects of continuous positive airway pressure on cardiac remodeling as assessed by cardiac biomarkers, echocardiography, and cardiac MRI. Chest 141(3):674–681. doi:10.1378/chest.11-0615